Agency for Healthcare Research and Quality

The Agency for Healthcare Research and Quality (AHRQ; pronounced "ark" by initiates and often "A-H-R-Q" by the public) is one of twelve agencies within the U.S. Department of Health and Human Services (HHS). The agency is headquartered in North Bethesda, Maryland, a suburb of Washington, D.C. (with a Rockville mailing address). It was established as the Agency for Health Care Policy and Research (AHCPR) in 1989 as a constituent unit of the Public Health Service (PHS) to enhance the quality, appropriateness, and effectiveness of health care services and access to care by conducting and supporting research, demonstration projects, and evaluations; developing guidelines; and disseminating information on health care services and delivery systems.

As part of the announced 2025 HHS reorganization, AHRQ is planned to be integrated into the new HHS Office of Strategy.

History

AHRQ's earliest predecessor was the National Center for Health Services Research and Development, established in 1968 within the short-lived PHS Health Services and Mental Health Administration (HSMHA) during the 1966–1973 PHS reorganizations. It was established largely through the efforts of members of the NIH Division of Research Grants Health Services Study Section. The new center quickly absorbed the PHS Division of Chronic Diseases, which dated back to 1949, in order to access the latter's larger budget.

When HSMHA was split up in 1973, the center was included in one of its successors, the Health Resources Administration. It was renamed the Bureau of Health Services Research that year, and then the National Center for Health Services Research in 1975.

In 1978 it was transferred to the Office of the Assistant Secretary for Health. In 1985 it was renamed the National Center for Health Services Research and Health Care Technology Assessment.

In 1989, the agency became its own operating agency within PHS, and was renamed Agency for Health Care Policy and Research (AHCPR) by the Omnibus Budget Reconciliation Act of 1989 (). However, AHCPR became controversial when it produced several guidelines that some thought would reduce medical drugs and procedures. This included concern from ophthalmologists on a cataract guideline and concern by the pharmaceutical industry over a reduction in the use of new drugs. When the agency produced a guideline that concluded that back pain surgery was unnecessary and potentially harmful, a lobbying campaign aided by Congressmen whose backs had been operated on changed the name of the agency and scaled back the guidelines program, which existed as the National Guideline Clearinghouse, until it was defunded in 2018.

AHCPR was reauthorized December 6, 1999, as the Agency for Healthcare Research and Quality (AHRQ) under the Healthcare Research and Quality Act of 1999, which amended Title IX of the Public Health Service Act (42 U.S.C. 299 et seq).

Funding

The 2015 budget for AHRQ was US$440 million, $24 million less than FY 2014. The budget includes $334 million in Public Health Service (PHS) Evaluation Funds, a decrease of $30 million from FY 2014, and $106 million from the Patient-Centered Outcomes Research Trust Fund, an increase of $13 million above FY 2014.

The FY 2015 budget is intended to ensure the Agency continues its progress on health services research to improve outcomes, affordability, and quality. The budget also supports the collection of information on health care spending and use through th
Healthcare Cost and Utilization Project
(HCUP) an
Medical Expenditure Panel Survey
(MEPS).

In July 2018, the National Guideline Clearinghouse (NGC) and the National Quality Measures Clearinghouse (NQMC), two longtime online resources from the AHRQ, were shut down because federal funding ceased to be available to them. Other stakeholders were exploring options for hosting the NGC ]; should that happen, it will return to the web.

Leadership

Carolyn Clancy was the director from 2002 to 2014. Richard Kronick was director from 2013 to March 2016. Sharon Arnold was acting director from February to April 2016, replacing Richard Kronick in February 2016. Andrew Bindman was the director of AHRQ from April 2016 until January 2017. Prior to joining AHRQ, Bindman served as faculty of UCSF School of Medicine. Gopal Khanna was appointed as Agency director on May 9, 2017, and resigned on January 11, 2021, in response to the January 6 Capitol riot. Following Khanna's resignation, deputy director David Meyers served as acting director from 2021 to 2022. Robert Otto Valdez was appointed director on February 27, 2022.

Divisions

The Agency has multiple offices and centers including the Center for Evidence and Practice Improvement (CEPI), the Center for Financing, Access and Trends, the Center for Delivery, Organization and Markets, the Center for Quality and Patient Safety, the Office of Management Services, the Office of Extramural Research and Priority Populations, and the Office of Communications. The Office of Communications was previously known as the Office of Communications and Knowledge Transfer.

Within CEPI, the Evidence-Based Practice Centers (EPCs) develop evidence reports and technology assessments on topics relevant to clinical and other health care organization and delivery issues—specifically those that are common, expensive, and/or significant for the Medicare and Medicaid populations. With this program, AHRQ serves as a "science partner" with private and public organizations in their efforts to improve the quality, effectiveness, and appropriateness of health care by synthesizing the evidence and facilitating the translation of evidence-based research findings. Topics are nominated by Federal and non-Federal partners such as professional societies, health plans, insurers, employers, and patient groups.

References

External links

Official site

Agency for Healthcare Research and Quality
in the ''Federal Register''

{{Authority control

Health care quality
Healthcare Research and Quality
Medical and health organizations based in Maryland